CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company
Phio Pharmaceuticals Corp.
Sign in to watch- Ticker
- PHIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453215903
- Phone
- (508) 767-3861
- Business address
- 411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
- Former names
- RXi Pharmaceuticals Corp
- Open-market buys, last 90 days
- $104,806
- in 9 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$104,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 55 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-13 | Kontulis Caitlin Secretary & Sr. Dir. Finance | Grant or award | +27,000 | 40,214 | ||
| 2019-02-13 | Dispersyn Gerrit President & COO | Grant or award | +55,000 | 71,350 | ||
| 2019-02-01 | CAUWENBERGH GEERT Chief Executive Officer | Grant or award | +21,470 | $0.38 | $8K | 306,898 |
| 2019-01-18 | CAUWENBERGH GEERT Chief Executive Officer | Grant or award | +23,729 | $0.34 | $8K | 285,428 |
| 2019-01-04 | CAUWENBERGH GEERT Chief Executive Officer | Grant or award | +23,139 | $0.35 | $8K | 261,699 |
| 2018-12-21 | CAUWENBERGH GEERT Chief Executive Officer | Grant or award | +27,445 | $0.30 | $8K | 238,560 |
| 2018-12-07 | CAUWENBERGH GEERT Chief Executive Officer | Grant or award | +21,882 | $0.37 | $8K | 211,115 |
| 2018-11-23 | CAUWENBERGH GEERT Chief Executive Officer | Grant or award | +25,941 | $0.31 | $8K | 189,233 |
| 2018-11-09 | CAUWENBERGH GEERT President & CEO | Grant or award | +18,698 | $0.43 | $8K | 163,292 |
| 2018-10-26 | CAUWENBERGH GEERT President & CEO | Grant or award | +18,519 | $0.44 | $8K | 144,594 |
| 2018-10-12 | CAUWENBERGH GEERT President & CEO | Grant or award | +17,230 | $0.47 | $8K | 126,075 |
| 2018-09-28 | CAUWENBERGH GEERT President & CEO | Grant or award | +73,587 | $1.17 | $86K | 108,845 |
| 2018-08-01 | Lockshin Curtis Director | Grant or award | +10,000 | 10,130 | ||
| 2018-08-01 | Freeman Jonathan E Director | Grant or award | +10,000 | 10,000 | ||
| 2018-08-01 | Dorman H. Paul Director | Grant or award | +10,000 | 10,375 | ||
| 2018-08-01 | Brownlie Keith L Director | Grant or award | +10,000 | 10,000 | ||
| 2018-08-01 | Bitterman Robert J Director | Grant or award | +10,000 | 10,440 | ||
| 2018-08-01 | CAUWENBERGH GEERT President & CEO | Grant or award | +21,000 | 35,258 | ||
| 2018-08-01 | CAUWENBERGH GEERT President & CEO | Grant or award · Stock option (right to buy) | +21,000 | 21,000 | ||
| 2018-08-01 | Dispersyn Gerrit Chief Development Officer | Grant or award | +16,000 | 16,350 |
Page 7 of 13 · 258 trades